Medical Affairs organizations face mounting pressure to deliver integrated insights and cross-functional coordination while managing increasingly sophisticated stakeholder engagement demands. As therapeutic programs, patient journeys, data, and technologies rapidly advance, Medical Affairs is positioned to deliver deeper understanding and original insights to internal and external communities.
Acquis empowers Medical Affairs teams to establish scientific leadership and drive measurable enterprise impact. We design thoughtful strategies and support operational excellence across diverse therapeutic areas, geographies, and stages of growth.
Acquis helps you establish Medical Affairs operations that integrate data systems, optimize stakeholder engagement, and coordinate cross-functional insights. We create integrated Medical Affairs capabilities that transform fragmented activities into strategic influence, delivering the scientific leadership and measurable enterprise impact that competitive therapeutic programs demand.
We implement AI-powered medical technology solutions that transform Medical Affairs from relationship managers into data-driven scientific leaders while maintaining regulatory compliance and scientific rigor.
We support integrated evidence strategies that serve regulatory, commercial, and medical stakeholders simultaneously, turning scattered research assets into compelling scientific narratives that position therapeutic programs as category leaders.
We design KOL engagement frameworks that transform scientific relationships into competitive advantages, helping Medical Affairs teams capture influential thought leader attention.
We design medical operating models that reinforce Medical Affairs as indispensable strategic partners who drive scientific leadership and patient impact.
We target operational efficiencies that showcase Medical Affair’s value delivery, focusing teams on scientific leadership, meaningful evidence generation, and patient outcomes. We also support strong Alliance Management capabilities and enhance navigation of cross-company ways of working.
We help Medical Affairs teams articulate strategic value in language executives understand, connecting scientific activities to business outcomes — market access acceleration, competitive differentiation, and budget impact — that make Medical Affairs essential.
We build MSL programs that prove field medical teams drive measurable business value rather than maintain expensive relationships, connecting MSL activities to competitive positioning and thought leadership executives recognize as strategic contributions.
We support patient advocacy relationships through targeted communications and forums for patients to be heard and acknowledged, cultivating and strengthening community connection and addressing true patient needs.
We develop scientific messaging, publications, and conference strategies that that smartly inform stakeholders and drive business outcomes by supporting thought leadership to build broader provider, payer, and advocate awareness at critical moments in the asset and patient journeys.
Our teams combine management consulting rigor with hands-on Medical Affairs experience across oncology, neurology, cardiovascular, immunology, and rare disease. We've managed KOL relationships that support regulatory goals, build evidence strategies under launch pressure, and navigate the cross-functional dynamics that make or break scientific leadership.
We build Medical Affairs capabilities that create measurable patient and business impact through early/accelerated access pathways, enhanced competitive positioning, and strengthened evidence outlooks. Our approach demonstrates Medical Affairs value in terms executives care about — time to market, scientific leadership, community connectivity and engagement, and therapeutic area positioning.
The biggest Medical Affairs challenges happen at organizational boundaries where medical strategy must compliantly coordinate across interdependent R&D timelines, commercial priorities, and market access requirements. We design solutions that optimize these critical handoffs while preserving medical independence, scientific credibility, and compliance guidelines.
We function as strategic partners who deliver measurable outcomes, not consultants who disappear after presenting recommendations. Whether building Medical Affairs capabilities for startup foundations or optimizing global medical operations, we take accountability for results that deliver durable impact.
One of the largest pharmaceutical companies in the world sought to optimize its alignment of the central medical affairs function with its local market companies across the globe.
Read More
To meet the demands of today’s trials, organizations need more than decentralized headcount tracking. They need a centralized, analytics-enabled resource management capability — one that provides full transparency into bandwidth, talent allocation, and strategic priorities across functions.
Read More
The clinical trial landscape is changing, driven by AI technologies that redefine what’s possible in therapeutic development. This revolution extends far beyond simple efficiency gains — AI fundamentally alters how trials are designed, conducted, monitored, and evaluated. Organizations that understand these shifts gain strategic advantages in speed-to-market, research quality, and patient-centricity.
Read More
In the final installment of the Accelerate series, we explore the expected success that awaits business leaders who effectively navigate the SAP Concur implementation journey.
Read More
To meet the demands of today’s trials, organizations need more than decentralized headcount tracking. They need a centralized, analytics-enabled resource management capability — one that provides full transparency into bandwidth, talent allocation, and strategic priorities across functions.
Read More
The clinical trial landscape is changing, driven by AI technologies that redefine what’s possible in therapeutic development. This revolution extends far beyond simple efficiency gains — AI fundamentally alters how trials are designed, conducted, monitored, and evaluated. Organizations that understand these shifts gain strategic advantages in speed-to-market, research quality, and patient-centricity.
Read More
In the final installment of the Accelerate series, we explore the expected success that awaits business leaders who effectively navigate the SAP Concur implementation journey.
Read More
How do you address Medical Affairs budget pressure while increasing strategic impact?
We help Medical Affairs teams demonstrate clear business value that justifies investment rather than just requesting budget protection. Our approach includes resource optimization that improves efficiency, measurement frameworks that prove impact to both patients and the organization, and strategic positioning that validates Medical Affairs indispensable to business success.
How quickly can Medical Affairs transformation show measurable business impact?
Timeline depends on organizational readiness and transformation scope, but our frameworks demonstrate measurable improvements in stakeholder engagement effectiveness, cross-functional coordination, and strategic positioning quickly — building toward longer-term business impact including accelerated market access and enhanced competitive advantages.
Why is cross-functional integration critical to Medical Affairs success?
Cross-functional integration transforms Medical Affairs from a support function into a strategic driver. Integration enables Medical Affairs to complement R&D priorities, inform commercial strategy, and accelerate market access — creating measurable business impact rather than just scientific activities.
What makes Medical Affairs transformation different from other organizational changes?
Medical Affairs transformation must balance strategic business impact with scientific integrity, therapeutic understanding, and regulatory compliance. Success requires maintaining the scientific excellence that makes Medical Affairs credible while positioning medical capabilities as competitive advantages that drive both patient impact and enterprise value.
Can Medical Affairs transformation work for both emerging and established organizations?
Our approach scales from building foundational Medical Affairs capabilities that drive early-stage scientific presence to optimizing established global medical operations for enhanced strategic impact. We tailor solutions to organizational maturity while ensuring Medical Affairs creates measurable enterprise value at every stage.
How do you prove Medical Affairs drives business value beyond traditional metrics?
We establish measurement frameworks that connect Medical Affairs activities to therapeutic and patient outcomes including accelerated regulatory approvals, expanded market access pathways, enhanced competitive positioning, and direct quality of life impact. Our approach demonstrates Medical Affairs value in language that CFOs and CEOs understand while maintaining scientific credibility and never losing sight of patient impact
Get in touch with the Acquis Medical Affairs experts
